JAZZ logo

Jazz Pharmaceuticals plc (JAZZ) Total expenses

Annual total expenses:

$3.51B+$89.46M(+2.62%)
December 31, 2024

Summary

  • As of today (September 1, 2025), JAZZ annual total expenses is $3.51 billion, with the most recent change of +$89.46 million (+2.62%) on December 31, 2024.
  • During the last 3 years, JAZZ annual total expenses has risen by +$84.92 million (+2.48%).
  • JAZZ annual total expenses is now -9.65% below its all-time high of $3.88 billion, reached on December 31, 2022.

Performance

JAZZ Total expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherJAZZincome statement metrics

Quarterly total expenses:

$1.76B+$773.80M(+78.13%)
June 30, 2025

Summary

  • As of today (September 1, 2025), JAZZ quarterly total expenses is $1.76 billion, with the most recent change of +$773.80 million (+78.13%) on June 30, 2025.
  • Over the past year, JAZZ quarterly total expenses has increased by +$908.92 million (+106.28%).
  • JAZZ quarterly total expenses is now at all-time high.

Performance

JAZZ Quarterly total expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherJAZZincome statement metrics

Total expenses Formula

Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses

JAZZ Total expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+2.6%+106.3%
3 y3 years+2.5%+96.4%
5 y5 years+114.2%+294.1%

JAZZ Total expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-9.7%+2.6%at high+114.3%
5 y5-year-9.7%+114.2%at high+294.1%
alltimeall time-9.7%>+9999.0%at high+9982.8%

JAZZ Total expenses History

DateAnnualQuarterly
Jun 2025
-
$1.76B(+78.1%)
Mar 2025
-
$990.38M(+10.4%)
Dec 2024
$3.51B(+2.6%)
$897.06M(+6.8%)
Sep 2024
-
$839.91M(-1.8%)
Jun 2024
-
$855.26M(-6.7%)
Mar 2024
-
$916.60M(-0.1%)
Dec 2023
$3.42B(-11.9%)
$917.78M(+11.2%)
Sep 2023
-
$825.32M(-3.2%)
Jun 2023
-
$852.88M(+3.6%)
Mar 2023
-
$823.39M(-32.1%)
Dec 2022
$3.88B(+13.4%)
$1.21B(+26.3%)
Sep 2022
-
$960.30M(+6.9%)
Jun 2022
-
$898.21M(+10.6%)
Mar 2022
-
$812.07M(-12.9%)
Dec 2021
$3.42B(+61.1%)
$932.08M(+4.6%)
Sep 2021
-
$890.95M(-20.1%)
Jun 2021
-
$1.12B(+129.6%)
Mar 2021
-
$485.75M(-8.7%)
Dec 2020
$2.12B(+29.7%)
$532.10M(+17.6%)
Sep 2020
-
$452.65M(+1.1%)
Jun 2020
-
$447.63M(-35.4%)
Mar 2020
-
$692.56M(+36.4%)
Dec 2019
$1.64B(+13.5%)
$507.75M(+16.6%)
Sep 2019
-
$435.43M(+59.9%)
Jun 2019
-
$272.24M(-35.6%)
Mar 2019
-
$422.99M(+33.4%)
Dec 2018
$1.44B(+27.7%)
$316.99M(-1.0%)
Sep 2018
-
$320.06M(-21.6%)
Jun 2018
-
$408.16M(+2.4%)
Mar 2018
-
$398.62M(+95.2%)
Dec 2017
$1.13B(+3.6%)
$204.19M(-41.4%)
Sep 2017
-
$348.33M(+20.6%)
Jun 2017
-
$288.78M(-0.3%)
Mar 2017
-
$289.54M(+3.4%)
Dec 2016
$1.09B(+9.6%)
$279.93M(-1.6%)
Sep 2016
-
$284.35M(+6.6%)
Jun 2016
-
$266.66M(+2.5%)
Mar 2016
-
$260.20M(+0.8%)
DateAnnualQuarterly
Dec 2015
$995.27M(-10.7%)
$258.12M(+2.1%)
Sep 2015
-
$252.91M(+3.0%)
Jun 2015
-
$245.63M(+2.9%)
Mar 2015
-
$238.60M(-3.2%)
Dec 2014
$1.11B(+69.9%)
$246.53M(-12.2%)
Sep 2014
-
$280.82M(+13.4%)
Jun 2014
-
$247.57M(-27.1%)
Mar 2014
-
$339.57M(+88.1%)
Dec 2013
$656.11M(+102.0%)
$180.48M(+15.1%)
Sep 2013
-
$156.75M(-5.6%)
Jun 2013
-
$166.07M(+8.7%)
Mar 2013
-
$152.81M(+773.4%)
Dec 2012
$324.83M(+120.5%)
$17.50M(-87.7%)
Sep 2012
-
$141.92M(+38.6%)
Jun 2012
-
$102.39M(+26.8%)
Mar 2012
-
$80.73M(+75.3%)
Dec 2011
$147.29M(+4.5%)
$46.06M(+12.9%)
Sep 2011
-
$40.81M(+30.1%)
Jun 2011
-
$31.36M(+8.0%)
Mar 2011
-
$29.05M(+0.5%)
Dec 2010
$141.00M(+4.2%)
$28.91M(-8.3%)
Sep 2010
-
$31.51M(-32.8%)
Jun 2010
-
$46.87M(+39.1%)
Mar 2010
-
$33.71M(+3.3%)
Dec 2009
$135.28M(-46.3%)
$32.63M(+0.5%)
Sep 2009
-
$32.48M(-7.5%)
Jun 2009
-
$35.11M(+0.1%)
Mar 2009
-
$35.06M(-54.2%)
Dec 2008
$251.85M(+23.4%)
$76.53M(+64.4%)
Sep 2008
-
$46.55M(-30.9%)
Jun 2008
-
$67.42M(+9.9%)
Mar 2008
-
$61.34M(-18.7%)
Dec 2007
$204.13M(+95.8%)
$75.50M(+84.9%)
Sep 2007
-
$40.83M(-24.6%)
Jun 2007
-
$54.13M(+60.7%)
Mar 2007
-
$33.67M
Dec 2006
$104.25M(-2.2%)
-
Dec 2005
$106.60M(+329.8%)
-
Dec 2004
$24.80M
-

FAQ

  • What is Jazz Pharmaceuticals plc annual total expenses?
  • What is the all time high annual total expenses for Jazz Pharmaceuticals plc?
  • What is Jazz Pharmaceuticals plc annual total expenses year-on-year change?
  • What is Jazz Pharmaceuticals plc quarterly total expenses?
  • What is the all time high quarterly total expenses for Jazz Pharmaceuticals plc?
  • What is Jazz Pharmaceuticals plc quarterly total expenses year-on-year change?

What is Jazz Pharmaceuticals plc annual total expenses?

The current annual total expenses of JAZZ is $3.51B

What is the all time high annual total expenses for Jazz Pharmaceuticals plc?

Jazz Pharmaceuticals plc all-time high annual total expenses is $3.88B

What is Jazz Pharmaceuticals plc annual total expenses year-on-year change?

Over the past year, JAZZ annual total expenses has changed by +$89.46M (+2.62%)

What is Jazz Pharmaceuticals plc quarterly total expenses?

The current quarterly total expenses of JAZZ is $1.76B

What is the all time high quarterly total expenses for Jazz Pharmaceuticals plc?

Jazz Pharmaceuticals plc all-time high quarterly total expenses is $1.76B

What is Jazz Pharmaceuticals plc quarterly total expenses year-on-year change?

Over the past year, JAZZ quarterly total expenses has changed by +$908.92M (+106.28%)
On this page